HRT Financial’s Applied Molecular Transport AMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-113,307
Closed -$17K – 3309
2023
Q3
$17K Buy
+113,307
New +$30.1K ﹤0.01% 2085
2022
Q1
– Sell
-64,459
Closed -$901K – 4079
2021
Q4
$901K Buy
64,459
+40,658
+171% +$801K 0.01% 1228
2021
Q3
$615K Buy
+23,801
New +$754K ﹤0.01% 1801

Other funds holding AMTI

HRT Financial's AMTI Position: Q4 2023 in Review

HRT Financial sold out of Applied Molecular Transport (AMTI) in Q4 2023, closing a stake of 113,307 shares — an estimated $17K sold.

HRT Financial first reported a position in AMTI in Q3 2021 and held it in 3 quarters. The position peaked at $901K in Q4 2021. 2 funds tracked by Wall St. Rank hold AMTI as of Q4 2023.

  • HRT Financial reported no remaining Applied Molecular Transport position as of Q4 2023 after selling out during the quarter.
  • HRT Financial sold 113,307 Applied Molecular Transport shares in Q4 2023, an estimated $17K.
  • HRT Financial first reported a position in Applied Molecular Transport in Q3 2021 and held it in 3 quarters.
  • HRT Financial's Applied Molecular Transport position peaked at $901K in Q4 2021.
  • 2 funds tracked by Wall St. Rank held Applied Molecular Transport as of Q4 2023.

Based on HRT Financial's 13F filing for Q4 2023, filed 9 Feb 2024.